You have landed on a page of the archived Cochrane Community website. This site is not being maintained or updated.

If you are looking for Cochrane Review evidence, please visit Cochrane’s evidence page.

If you are a Cochrane contributor looking for Community resources, please visit the new Cochrane Community website.

Hepatitis B

Warning: Parameter 2 to onepixelout_swftools_flashvars() expected to be a reference, value given in module_invoke() (line 476 of /var/www/archive/includes/

To browse Podcasts by topic, please visit the new Cochrane Summaries site here

Developed in collaboration with the Evidence-Based Migrant Health Guidelines Team

Dr. Chris Greenaway will describe the key points of the Hepatitis B review of the Canadian Collaboration for Immigrant and Refugee Health Evidence-based clinical guidelines.

Key points

  • Newly arrived immigrants and refugees have aprevalence of chronic hepatitis B infection of about 4% as compared with 0.5% in the Canadian-born population.
  • Immigrants have increased mortality from chronic and viral hepatitis and hepatocellular carcinoma than the Canadian-born population, likely primarily because of increased prevalence of undetected and untreated chronic hepatitis B infection.
  • Immigrants would benefit from screening for chronic hepatitis B.
  • Immigrants would benefit from hepatitis B vaccination.

CMAJ evidence review

Evidence Based Migrant Health Network

Play Now!

You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialize correctly.

Download [mp3]  | Read Review
Updated on: May 7, 2012, 11:49

Comments for improvement or correction are welcome.